Size-dependent tissue kinetics of PEG-coated gold nanoparticles.

Gold nanoparticles (AuNPs) can be used in various biomedical applications, however, very little is known about their size-dependent in vivo kinetics. Here, we performed a kinetic study in mice with different sizes of PEG-coated AuNPs. Small AuNPs (4 or 13nm) showed high levels in blood for 24h and were cleared by 7days, whereas large (100nm) AuNPs were completely cleared by 24h. All AuNPs in blood re-increased at 3months, which correlated with organ levels. Levels of small AuNPs were peaked at 7days in the liver and spleen and at 1month in the mesenteric lymph node, and remained high until 6months, with slow elimination. In contrast, large AuNPs were taken up rapidly ( approximately 30min) into the liver, spleen, and mesenteric lymph nodes with less elimination phase. TEM showed that AuNPs were entrapped in cytoplasmic vesicles and lysosomes of Kupffer cells and macrophages of spleen and mesenteric lymph node. Small AuNPs transiently activated CYP1A1 and 2B, phase I metabolic enzymes, in liver tissues from 24h to 7days, which mirrored with elevated gold levels in the liver. Large AuNPs did not affect the metabolic enzymes. Thus, propensity to accumulate in the reticuloendothelial organs and activation of phase I metabolic enzymes, suggest that extensive further studies are needed for practical in vivo applications.

[1]  T. Davis,et al.  The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.

[2]  Y. Kawabata,et al.  Lung tumor induced by long-term inhalation or intratracheal instillation of diesel exhaust particles. , 1997, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[3]  K. Donaldson,et al.  Signs of stress , 2006, Nature nanotechnology.

[4]  J. Hubbell,et al.  Functionalization of polysulfide nanoparticles and their performance as circulating carriers. , 2008, Biomaterials.

[5]  Hui Li,et al.  Nanoparticle-driven DNA damage mimics irradiation-related carcinogenesis pathways , 2008, European Respiratory Journal.

[6]  Keishiro Tomoda,et al.  Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.

[7]  J. Stegeman,et al.  Oxidative inactivation of cytochrome P-450 1A (CYP1A) stimulated by 3,3',4,4'-tetrachlorobiphenyl: production of reactive oxygen by vertebrate CYP1As. , 1999, Molecular pharmacology.

[8]  Beom Seok Han,et al.  Comparison of gene expression profiles in mice liver following intravenous injection of 4 and 100 nm-sized PEG-coated gold nanoparticles. , 2009, Toxicology letters.

[9]  R. Barouki,et al.  Involvement of reactive oxygen species in the metabolic pathways triggered by diesel exhaust particles in human airway epithelial cells. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[10]  M. Grunze,et al.  Factors that determine the protein resistance of oligoether self-assembled monolayers --internal hydrophilicity, terminal hydrophilicity, and lateral packing density. , 2003, Journal of the American Chemical Society.

[11]  P. L. Bryant,et al.  EGF and TGF-alpha expression influence the developmental toxicity of TCDD: dose response and AhR phenotype in EGF, TGF-alpha, and EGF + TGF-alpha knockout mice. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[12]  L. Birnbaum,et al.  Comparative ability of various PCBs, PCDFs, and TCDD to induce cytochrome P450 1A1 and 1A2 activity following 4 weeks of treatment. , 1993, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[13]  D. Astruc,et al.  Gold Nanoparticles: Assembly, Supramolecular Chemistry, Quantum‐Size‐Related Properties, and Applications Toward Biology, Catalysis, and Nanotechnology. , 2004 .

[14]  David M. Brown,et al.  Proinflammogenic Effects of Low-Toxicity and Metal Nanoparticles In Vivo and In Vitro: Highlighting the Role of Particle Surface Area and Surface Reactivity , 2007, Inhalation toxicology.

[15]  S. Joo,et al.  Control of gold nanoparticle aggregates by manipulation of interparticle interaction. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[16]  V. Castranova,et al.  Diesel Exhaust Particle-Induced Alterations of Pulmonary Phase I and Phase II Enzymes of Rats , 2003, Journal of toxicology and environmental health. Part A.

[17]  Mina Choi,et al.  The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. , 2009, Toxicology letters.

[18]  Vicki Stone,et al.  Efficacy of Simple Short-Term in Vitro Assays for Predicting the Potential of Metal Oxide Nanoparticles to Cause Pulmonary Inflammation , 2008, Environmental health perspectives.

[19]  Sue-N. Park,et al.  Pulmonary toxicity and kinetic study of Cy5.5-conjugated superparamagnetic iron oxide nanoparticles by optical imaging. , 2009, Toxicology and applied pharmacology.

[20]  Valery V Tuchin,et al.  Circulation and distribution of gold nanoparticles and induced alterations of tissue morphology at intravenous particle delivery , 2009, Journal of biophotonics.

[21]  P. L. Bryant,et al.  EGF and TGF-α Expression Influence the Developmental Toxicity of TCDD: Dose Response and AhR Phenotype in EGF, TGF-α, and EGF + TGF-α Knockout Mice , 2003 .

[22]  Xiaohua Huang,et al.  Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. , 2005, Nano letters.

[23]  Wei Qian,et al.  The effect of plasmon field on the coherent lattice phonon oscillation in electron-beam fabricated gold nanoparticle pairs. , 2007, Nano letters.

[24]  B. R. Smith,et al.  Role of cytochrome P-450 and related enzymes in the pulmonary metabolism of xenobiotics. , 1984, Environmental health perspectives.

[25]  Bong Hyun Chung,et al.  Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. , 2009, Toxicology and applied pharmacology.

[26]  Catherine J. Murphy,et al.  Wet Chemical Synthesis of High Aspect Ratio Cylindrical Gold Nanorods , 2001 .

[27]  S. Takenoshita,et al.  Lung carcinogenesis and formation of 8-hydroxy-deoxyguanosine in mice by diesel exhaust particles. , 1997, Carcinogenesis.

[28]  J. Whitlock,et al.  Induction of cytochrome P4501A1. , 1999, Annual review of pharmacology and toxicology.

[29]  G. Frens.  Controlled Nucleation for the Regulation of the Particle Size in Monodisperse Gold Suspensions , 1973 .

[30]  Vincent Castranova,et al.  Surface area of particle administered versus mass in determining the pulmonary toxicity of ultrafine and fine carbon black: comparison to ultrafine titanium dioxide , 2009, Particle and Fibre Toxicology.

[31]  S. Krol,et al.  Electrophoretic characterization of gold nanoparticles functionalized with human serum albumin (HSA) and creatine. , 2009, Journal of colloid and interface science.

[32]  Mansoo Choi,et al.  Body Distribution of Inhaled Fluorescent Magnetic Nanoparticles in the Mice , 2008, Journal of occupational health.

[33]  D. P. O'Neal,et al.  Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. , 2004, Cancer letters.

[34]  May D. Wang,et al.  In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags , 2008, Nature Biotechnology.

[35]  Tae-Jong Yoon,et al.  Toxicity and tissue distribution of magnetic nanoparticles in mice. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[36]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[37]  Vincent M Rotello,et al.  Functionalized gold nanoparticles for drug delivery. , 2007, Nanomedicine.

[38]  G. Upadhyay,et al.  Resveratrol modulates pyrogallol-induced changes in hepatic toxicity markers, xenobiotic metabolizing enzymes and oxidative stress. , 2008, European journal of pharmacology.

[39]  K. Leong,et al.  Multifunctional nanorods for gene delivery , 2003, Nature materials.

[40]  Petra Krystek,et al.  Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. , 2008, Biomaterials.

[41]  Manuela Semmler-Behnke,et al.  Biodistribution of 1.4- and 18-nm gold particles in rats. , 2008, Small.

[42]  David J. Robertson,et al.  Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and X-ray-contrast-imaging studies. , 2007, Small.

[43]  Alaaldin M. Alkilany,et al.  Gold nanoparticles in biology: beyond toxicity to cellular imaging. , 2008, Accounts of chemical research.

[44]  Dong Liang,et al.  Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. , 2009, Biomaterials.

[45]  Gan-Moog Chow,et al.  In vivo toxic studies and biodistribution of near infrared sensitive Au–Au2S nanoparticles as potential drug delivery carriers , 2008, Journal of materials science. Materials in medicine.

[46]  V. Castranova,et al.  Effects of exposure to diesel exhaust particles (DEP) on pulmonary metabolic activation of mutagenic agents. , 2004, Mutation research.